Published in Mov Disord on March 01, 2006
Association between late-life social activity and motor decline in older adults. Arch Intern Med (2009) 2.26
The evolution of mild parkinsonian signs in aging. J Neurol (2014) 1.47
Loneliness and the rate of motor decline in old age: the Rush Memory and Aging Project, a community-based cohort study. BMC Geriatr (2010) 1.35
Combinations of motor measures more strongly predict adverse health outcomes in old age: the rush memory and aging project, a community-based cohort study. BMC Med (2011) 1.33
Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders. Mov Disord (2010) 1.09
Loss of motor function in preclinical Alzheimer's disease. Expert Rev Neurother (2011) 0.91
Vibratory thresholds and mobility in older persons. Muscle Nerve (2009) 0.87
Contributions of mild parkinsonian signs to gait performance in the elderly. Age (Dordr) (2014) 0.86
Neuroticism, extraversion, and motor function in community-dwelling older persons. Am J Geriatr Psychiatry (2013) 0.85
The role of prefrontal cortex during postural control in Parkinsonian syndromes a functional near-infrared spectroscopy study. Brain Res (2015) 0.84
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs. Alzheimers Res Ther (2016) 0.75
Can a screening questionnaire accurately identify mild Parkinsonian signs? Neuroepidemiology (2012) 0.75
Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet (2008) 5.66
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Physical activity, diet, and risk of Alzheimer disease. JAMA (2009) 4.11
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A (2004) 3.73
A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52
Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol (2005) 3.10
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69
Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39
Cognitive decline and literacy among ethnically diverse elders. J Geriatr Psychiatry Neurol (2005) 2.33
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32
The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol (2007) 2.21
Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol (2006) 2.21
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20
Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia (2006) 2.17
Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol (2009) 2.06
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol (2009) 2.05
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med (2012) 1.99
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91
Measures of adiposity and dementia risk in elderly persons. Arch Neurol (2007) 1.88
Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci U S A (2008) 1.84
Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Arch Neurol (2008) 1.81
Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol (2004) 1.79
Attitudes and practices among internists concerning genetic testing. J Genet Couns (2012) 1.75
Disparities in the recording of Parkinson's disease on death certificates. Mov Disord (2005) 1.75
An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol (2006) 1.73
Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A (2010) 1.73
Lack of familial aggregation of Parkinson disease and Alzheimer disease. Arch Neurol (2004) 1.67
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol (2010) 1.56
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord (2007) 1.55
Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol (2012) 1.55
Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord (2004) 1.54
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord (2002) 1.52
Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol (2013) 1.52
Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol (2005) 1.48
Essential tremor is associated with dementia: prospective population-based study in New York. Neurology (2009) 1.45
Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet (2010) 1.44
A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol (2005) 1.42
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol (2010) 1.38
Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology (2010) 1.37
Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet (2011) 1.36
Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol (2004) 1.35
Seizures in Alzheimer disease: who, when, and how common? Arch Neurol (2009) 1.34
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr (2005) 1.32
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Med Genet (2006) 1.30
Disclosures of Huntington disease risk within families: patterns of decision-making and implications. Am J Med Genet A (2007) 1.28
Parkinsonian signs in older people: prevalence and associations with smoking and coffee. Neurology (2003) 1.27
Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord (2004) 1.27
Case-control study of the parkin gene in early-onset Parkinson disease. Arch Neurol (2006) 1.26
Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. J Gerontol A Biol Sci Med Sci (2010) 1.22
Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet (2006) 1.19
Association of C-reactive protein with cognitive impairment. Arch Neurol (2010) 1.19
Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol (2002) 1.17
A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging (2005) 1.17
Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord (2007) 1.16
Telephone-based identification of mild cognitive impairment and dementia in a multicultural cohort. Arch Neurol (2011) 1.15
Longitudinal assessment of patient dependence in Alzheimer disease. Arch Neurol (2002) 1.14
Interrater agreement in the assessment of motor manifestations of Huntington's disease. Mov Disord (2005) 1.13
Plasma ß-amyloid and cognitive decline. Arch Neurol (2010) 1.13
Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. J Am Geriatr Soc (2003) 1.12
Decision-making about reproductive choices among individuals at-risk for Huntington's disease. J Genet Couns (2007) 1.11
Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging (2008) 1.10
Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders. Mov Disord (2010) 1.09
Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing (2008) 1.07
Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene. Mov Disord (2007) 1.07
Incidence and prevalence of dementia in elderly adults with mental retardation without down syndrome. Am J Ment Retard (2004) 1.07
Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia. Arch Neurol (2007) 1.06
The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease. Arch Neurol (2003) 1.06
The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline. J Int Neuropsychol Soc (2003) 1.05
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. Am J Hum Genet (2012) 1.05
Dementia in adults with mental retardation: assessment at a single point in time. Am J Ment Retard (2004) 1.05
Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome. Neurosci Lett (2007) 1.04
Contribution of aging to the severity of different motor signs in Parkinson disease. Arch Neurol (2005) 1.04
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. J Clin Exp Neuropsychol (2010) 1.03
Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment. Dement Geriatr Cogn Disord (2008) 1.03
Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for training. J Genet Couns (2013) 1.03
Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. Mov Disord (2002) 1.03
Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiol Aging (2005) 1.01
The roles of family members, health care workers, and others in decision-making processes about genetic testing among individuals at risk for Huntington disease. Genet Med (2007) 1.00
Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Mov Disord (2004) 0.99
Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics. Arch Neurol (2006) 0.98
Tracking motor impairments in the progression of Huntington's disease. Mov Disord (2013) 0.98
Quantitative brain measurements in community-dwelling elderly persons with mild parkinsonian signs. Arch Neurol (2008) 0.98
Energy balance in early-stage Huntington disease. Am J Clin Nutr (2005) 0.97
Incidence and temporal patterns of adaptive behavior change in adults with mental retardation. Am J Ment Retard (2002) 0.96